Works matching AU Kubo, Akihito

Results: 41
    1
    2
    3
    4
    5
    6
    7
    8

    Therapeutic and preventive antiemetic effect of aprepitant in Japanese patients with thoracic malignancies who truly need it.

    Published in:
    Supportive Care in Cancer, 2015, v. 23, n. 4, p. 905, doi. 10.1007/s00520-014-2430-x
    By:
    • Ito, Sumiyo;
    • Tsukiyama, Ikuto;
    • Ando, Masahiko;
    • Katakami, Masayo;
    • Hamanaka, Rie;
    • Kosaka, Kenshi;
    • Matsubara, Ayako;
    • Nishimura, Masaki;
    • Tanaka, Hiroyuki;
    • Asai, Nobuhiro;
    • Yokoe, Norihito;
    • Takahashi, Ayumu;
    • Baba, Kenji;
    • Matsuura, Katsuhiko;
    • Yamaguchi, Etsuro;
    • Kubo, Akihito
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Early Pharmacodynamic Assessment Using <sup>18</sup>F-Fluorodeoxyglucose Positron-Emission Tomography on Molecular Targeted Therapy and Cytotoxic Chemotherapy for Clinical Outcome Prediction.

    Published in:
    Clinical Lung Cancer, 2014, v. 15, n. 3, p. 182, doi. 10.1016/j.cllc.2014.01.001
    By:
    • Masaki Kanazu;
    • Kaoru Maruyama;
    • Masahiko Ando;
    • Kazuhiro Asami;
    • Mari Ishii;
    • Kazutaka Uehira;
    • Shojiro Minomo;
    • Yoshinobu Matsuda;
    • Tomoya Kawaguchi;
    • Shinji Atagi;
    • Yoji Ogawa;
    • Yoko Kusunoki;
    • Minoru Takada;
    • Akihito Kubo
    Publication type:
    Article
    23
    24

    Bevacizumab beyond disease progression after first-line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non-small cell lung cancer (West Japan Oncology Group 5910L): An open-label, randomized, phase 2 trial.

    Published in:
    2016
    By:
    • Takeda, Masayuki;
    • Yamanaka, Takeharu;
    • Seto, Takashi;
    • Hayashi, Hidetoshi;
    • Azuma, Koichi;
    • Okada, Morihito;
    • Sugawara, Shunichi;
    • Daga, Haruko;
    • Hirashima, Tomonori;
    • Yonesaka, Kimio;
    • Urata, Yoshiko;
    • Murakami, Haruyasu;
    • Saito, Haruhiro;
    • Kubo, Akihito;
    • Sawa, Toshiyuki;
    • Miyahara, Eiji;
    • Nogami, Naoyuki;
    • Nakagawa, Kazuhiko;
    • Nakanishi, Yoichi;
    • Okamoto, Isamu
    Publication type:
    journal article
    25
    26

    Propensity score analysis of overall survival between first‐ and second‐generation EGFR‐TKIs using real‐world data.

    Published in:
    Cancer Science, 2020, v. 111, n. 10, p. 3705, doi. 10.1111/cas.14560
    By:
    • Ito, Kentaro;
    • Murotani, Kenta;
    • Kubo, Akihito;
    • Kunii, Eiji;
    • Taniguchi, Hirokazu;
    • Shindoh, Joe;
    • Asada, Kazuhiro;
    • Imaizumi, Kazuyoshi;
    • Takahashi, Kosuke;
    • Karayama, Masato;
    • Okuno, Motoyasu;
    • Inui, Naoki;
    • Hataji, Osamu;
    • Morikawa, Sayako;
    • Hayai, Shunsaku;
    • Suda, Takafumi;
    • Abe, Takashi;
    • Tsuda, Takeshi;
    • Yamagichi, Teppei;
    • Kimura, Tomoki
    Publication type:
    Article
    27
    28
    29

    Impact of somatic mutations on prognosis in resected non‐small‐cell lung cancer: The Japan Molecular Epidemiology for lung cancer study.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 7, p. 2343, doi. 10.1002/cam4.2897
    By:
    • Tamiya, Akihiro;
    • Koh, Yasuhiro;
    • Isa, Shun‐ichi;
    • Kubo, Akihito;
    • Ando, Masahiko;
    • Saka, Hideo;
    • Yoshimoto, Naoki;
    • Takeo, Sadanori;
    • Adachi, Hirofumi;
    • Tagawa, Tsutomu;
    • Kawashima, Osamu;
    • Yamashita, Motohiro;
    • Kataoka, Kazuhiko;
    • Takenoyama, Mitsuhiro;
    • Takeuchi, Yukiyasu;
    • Watanabe, Katsuya;
    • Matsumura, Akihide;
    • Kawaguchi, Tomoya
    Publication type:
    Article
    30
    31
    32
    33
    34

    Epidermal growth factor receptor tyrosine kinase inhibitors in previously treated advanced non-small-cell lung cancer with wild-type EGFR.

    Published in:
    Expert Opinion on Pharmacotherapy, 2016, v. 17, n. 2, p. 193, doi. 10.1517/14656566.2016.1109635
    By:
    • Mitsuoka, Shigeki;
    • Kawaguchi, Tomoya;
    • Kubo, Akihito;
    • Isa, Shun-ichi;
    • Asai, Kazuhisa;
    • Uji, Masato;
    • Watanabe, Tetsuya;
    • Sawa, Kenji;
    • Yoshimoto, Naoki;
    • Oka, Takako;
    • Nakai, Toshiyuki;
    • Suzumura, Tomohiro;
    • Tanaka, Hidenori;
    • Matsuura, Kuniomi;
    • Kimura, Tatsuo;
    • Yoshimura, Naruo;
    • Kudoh, Shinzoh;
    • Hirata, Kazuto
    Publication type:
    Article
    35
    36
    37

    The Role of Smoking Status on the Progression-Free Survival of Non-Small Cell Lung Cancer Patients Harboring Activating Epidermal Growth Factor Receptor (EGFR) Mutations Receiving First-Line EGFR Tyrosine Kinase Inhibitor Versus Platinum Doublet Chemotherapy: A Meta-Analysis of Prospective Randomized Trials

    Published in:
    Oncologist, 2015, v. 20, n. 3, p. 307, doi. 10.1634/theoncologist.2014-0285
    By:
    • Hasegawa, Yoshikazu;
    • Ando, Masahiko;
    • Maemondo, Makoto;
    • Yamamoto, Satomi;
    • Isa, Shun‐ichi;
    • Saka, Hideo;
    • Kubo, Akihito;
    • Kawaguchi, Tomoya;
    • Takada, Minoru;
    • Rosell, Rafael;
    • Kurata, Takayasu;
    • Ou, Sai‐Hong Ignatius
    Publication type:
    Article
    38

    EGFR R497K polymorphism is a favorable prognostic factor for advanced lung cancer.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2009, v. 135, n. 2, p. 313, doi. 10.1007/s00432-008-0464-5
    By:
    • Sasaki, Hidefumi;
    • Okuda, Katsuhiro;
    • Shimizu, Shigeki;
    • Takada, Minoru;
    • Kawahara, Masaaki;
    • Kitahara, Naoto;
    • Okumura, Meinoshin;
    • Matsumura, Akihide;
    • Iuchi, Keiji;
    • Kawaguchi, Tomoya;
    • Kubo, Akihito;
    • Kawano, Osamu;
    • Yukiue, Haruhiro;
    • Yano, Motoki;
    • Fujii, Yoshitaka
    Publication type:
    Article
    39
    40
    41